Remove COVID-19 Remove Licensing Remove Presentation Remove World Health
article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. As a result, it publicly promised that “ while the pandemic continues, Moderna will not enforce our COVID-19 related patents against those making vaccines intended to combat the pandemic.”

article thumbnail

Reclaiming Global Public Health

Bill of Health

By December 2020, the world had astonishingly powerful tools against COVID-19. Patents and trade secrets empower private actors to make decisions about pricing, production, and supply of important medical technologies — in short, about public health. By Zain Rizvi. reached the one million death mark.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

A new template for the Certificate of a Pharmaceutical Product will be put into use in line with China’s pharmaceutical export practices and the latest World Health Organization (WHO) guidelines. A concerted and collaborative effort is essential to address this threat to global health, economies, and security effectively.

article thumbnail

COVID-19: As Omicron Variant Spreads, Let’s Not Repeat Rookie Mistakes

HIT Consultant

No one should be surprised there’s another COVID variant on the loose, and yet seemingly, everyone is. The variant, named Omicron (the fifteenth letter in the Greek alphabet), was first reported to the World Health Organisation (WHO) by South Africa on November 24th. billion since the start of the pandemic.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

19 Medical Rehabilitation Equipment. The EC presented a first draft for public comment to the revision of Annex 1 in 2017. Medicine shortages and reduced availability of medicine represent an increasing issue across the European Union (EU) and the globe, which has been amplified by the COVID-19 pandemic.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – July/August

SQA

Health Canada. Counterfeit COVID-19 Antigen Rapid Test Kits Found in Ontario, 05 August 2022. Health Canada is warning consumers about counterfeit BTNX Rapid Response COVID-19 antigen rapid test kits (25-pack boxes) found in Ontario. Health Advance Inc. device identifier “COV-19C25.”

article thumbnail

Biden Administration Unveils Long-Awaited COVID-19 Rules For Large Employers and Healthcare Workers

Health Law RX

The first rule, issued by the Occupational Safety and Health Administration (the “OSHA Rule”), will require private employers with 100 or more employees to ensure that each of their workers is either fully vaccinated, or tests negative for COVID-19 at least once per week. The OSHA Rule. and wear a face covering.” Verification.